UnitedHealth Group Incorporated (NYSE:UNH) is J. W. Coons Advisors LLC’s 9th Largest Position

J. W. Coons Advisors LLC lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% in the third quarter, Holdings Channel reports. The firm owned 10,745 shares of the healthcare conglomerate’s stock after selling 65 shares during the quarter. UnitedHealth Group accounts for 1.6% of J. W. Coons Advisors LLC’s investment portfolio, making the stock its 9th biggest holding. J. W. Coons Advisors LLC’s holdings in UnitedHealth Group were worth $6,282,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the business. Braun Stacey Associates Inc. grew its stake in shares of UnitedHealth Group by 6.0% in the 3rd quarter. Braun Stacey Associates Inc. now owns 45,941 shares of the healthcare conglomerate’s stock valued at $26,861,000 after purchasing an additional 2,599 shares during the last quarter. GLOBALT Investments LLC GA raised its stake in shares of UnitedHealth Group by 112.1% during the 3rd quarter. GLOBALT Investments LLC GA now owns 12,903 shares of the healthcare conglomerate’s stock worth $7,544,000 after buying an additional 6,819 shares in the last quarter. AMG National Trust Bank increased its holdings in UnitedHealth Group by 4.6% in the third quarter. AMG National Trust Bank now owns 17,673 shares of the healthcare conglomerate’s stock valued at $10,333,000 after buying an additional 778 shares in the last quarter. Aljian Capital Management LLC boosted its position in shares of UnitedHealth Group by 14.2% in the 3rd quarter. Aljian Capital Management LLC now owns 16,243 shares of the healthcare conglomerate’s stock worth $9,497,000 after buying an additional 2,017 shares in the last quarter. Finally, Prudent Man Advisors LLC lifted its holdings in shares of UnitedHealth Group by 28.5% in the third quarter. Prudent Man Advisors LLC now owns 2,963 shares of the healthcare conglomerate’s stock valued at $1,732,000 after purchasing an additional 658 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have weighed in on UNH. Bank of America dropped their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Royal Bank of Canada decreased their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Truist Financial reissued a “buy” rating and issued a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Morgan Stanley cut their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Finally, Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Three investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Trading Down 0.2 %

NYSE:UNH opened at $592.23 on Monday. The stock has a market cap of $545.02 billion, a price-to-earnings ratio of 38.58, a PEG ratio of 1.74 and a beta of 0.58. The business has a fifty day moving average of $582.84 and a 200-day moving average of $549.98. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the prior year, the firm posted $6.56 earnings per share. The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.